Page 14 - 81_02

Problems associated with the emission of pharmaceutical products to the environment
viabilidad del tratamiento médico, especialmente en los
países en los que el acceso a los cuidados sanitarios es
todavía limitado”.
9. AGRADECIMIENTOS
Al Profesor D. Ángel Concheiro Nine, catedrático de la
Facultade de Farmacia de la USC, por las sugerencias y
recomendaciones aportadas al original de este trabajo.
10. BIBLIOGRAFÍA
1. Coats JR. Metcalf RL, Lu P-Y, Brown DD., Williams
JF, Hansen LG.. Model Ecosystem Evaluation of the
Environmental Impacts of the Veterinary Drugs
Phenotiazine, Sulfametazina, Clopidor and
Diethylstilbestrol. Envir. Health Perspct 1976; 18: 167-79. 16. Environmental Agency. Res. Develop. Tech. Rep.
2. Chiu S-H., Green ML. Baylis FP. Eline D. Rosegay A,
Meriwether H. and Jacob TA. Absortion, Tissue
Distribution and Excrepcion of Tritium-Lavelled
Ivermectin in Cattle, Sheep and Rat. J. Agric.Food. Chem.
1990; 38: 2072-2078.
3. Holter PC,Sommer,J., Gronvold J and Madsen M .
Effects of ivermectin treatment on the atetention of dung
beetles to cow pats. Bull. Entomol. Research 1993; 83: 53-
58.
4. Jacobsen P. and Berglind L. Persistence of
Oxytetracycline in Sediments from Fish Farms.
Aquaculture, 1988 ; 70: 365-370
5. Björklund H, Bondestam J and Bylund G. Residues of
oxolinic acid andoxytetracicycline in fish and sediments
from fish farms. Thesis. Departament of Biology. Abo
Akademi University. Finland.1991
6. Ervik A. Thorsen B, Eriksen V, Lunestad BT and
Samuelsen OB. Impact of administering antibacterial
agents on wild fish and blue mussels Mytilus edulis in the
vicinity of fish farms. Dis. Aqual. Org. 1994; 18: 45-51.
7. Schneider J. Problems related to the usage of veterinary
drugs in aquaculture – a review. Química Analítica. 1994;
13 (supp.1): S34 – S42.
8 . Watts CD, Craythorne M ,Fielding and Steel CP.
Identification of Non-volatile Organics in Water Using
Field Desorption Mass Spectrometry and High
Performance Liquid Choromatography. 3e d. European
Simposium on organic Micopollutents in Water (ed.)
Angeletti, A and Bjorseth DD. (pags. 120-131). Reidel Pub
C. Dordrech.1993.
9. Aerne GW, English J and Marks V. The role of
immunopassay in the analysis of microcontaminants in
river samples. Ecotoxcology and Environm Safey. 1985; 9:
79-83.
10. Richardson ML and Bowron JM. The fate of
Pharmaceuticals chemicals in the aquatic environment- A
review. J. Pharm. Pharmacol. 1985; 37: 1-12.
11. Stumpf M, Ternes, TA., Haberer,K, Seel, P and
Baumann W. Nachweis von Arzneimittelrücksatänden in
Klärangen und Flicssgewässern. Von Wasser, 1996; 86:
291-303.
12. Gartiser SL, Brinker, A, Uhl, R, Willmund M,
@Real Academia Nacional de Farmacia. Spain
Krümmerer K. and Daschner F. Investigation of hospital
effluents – the example of the Friburg university hospital.
Industrialwässer. 1994; 9: 1618-1624.
13. Giuliana F, Koller T, Würgler FE. and Widmer RM.
Detection of genotoxic activity in native hospital water by
the umuC test. Mutation Res. 1996; 368: 49-57.
14. Christensen FM. Pharmaceuticals in the Environment -
A Human Risk? Regulat. Toxicol. Pharmacology, 1998;
28, 3:212-221.
15. Kümmerer K. (Ed.) Pharmaceuticals in the
Environment. Sources, Fate, Effects and Risks. 3rd ed.
Springer-Verlag. Berlin., 2008.
P390. Review of Human Pharmaceuticals in the
Environment. WRc , Swindon, Wilts, UK. 2000.
17. Daughton CG. y Jones-Lepp, TL (Eds.)
Pharmaceuticals and Perdsonal Care Products in the
Environment: Scientific and Regulatory Issues.
ACS/Oxford Univ. Press. Washington DC 2001.
18. Dietrich DR , Webb SF. y Petry T. (Eds.) Spots
Pollutants: Pharmaceuticals in the Environment Elsevier
Academic Press. New York, 2005.
19. AWWA Ocurrence Survey of Pharmaceutically Active
Compounds. AWWA Res. Found. USA. 2005
20. Williams R T. (Ed.) Assessing Impacts on Aquatic
Ecosystems. SETAC (Soc. Env. Tox. And Chem.).
Pensacola, Fl., 2005.
21. Ternes TA. y Joss A. (Eds.) Human Pharmaceuticals,
hormones and Fragances. The challenge of micropollutants
in urban water management. IWA Pub. Londres 2006
22. Petrovic M, Pérez S. y Barceló D. (Eds.) Analysis,
Removal, Effects and Risks of Pharmaceuticals in the
Water Cycle. 2007, 2nd ed. 2013
23. Aga D. Fate of Pharmaceuticals in the Environment
and the Water Treatments Plants. CRC Press. Boca Raton.
Fl. 2008
24. Rahman SZ , Shahid M. y Gupta V. (Eds. ) An
Introduction to Environmental Pharmacology. Ibn Sina
Academia, India 2008
25. Crane M, Boxall AB y Berrett K. (Eds.) Veterinary
Medicines in the Environment SETAC Press. Pensacola
(Fl). 2009
26. Kümmerer K y Hempel M. (Eds.) Green and
Sustainable Pharmacy. Springer-Verlag. Berlin 2010.
27. Roig B. (Ed.) Pharmaceuticals in the Environment.
Current knowledge and need assessment to reduce
presence and impact. IWA Pub. Londres 2010.
28. Brooks TA, Huggett DB. (Eds.) Human
Pharmaceuticals in the Environment: Current and Future
perspectives. Springer. New York 2012.
29. BIO Intelligence Service. Study on the Environmentl
risks of medicinal products. Executive Agency for Health
and Consumers. Paris 2013.
30. Oaks JL, Gilbert M, Virani MZ, Watson, RT, Meteyer,
CU, Ridetout, BA, Shivaprasad HL, Ahmed S, Chaudrhry
MJ, Arshad M, Madmood S, y Khan AA . Diclofenac in
97